Literature DB >> 8788070

The effect of prolonged treatment with imipramine and electroconvulsive shock on the levels of endogenous enkephalins in the nucleus accumbens and the ventral tegmentum of the rat.

M Dziedzicka-Wasylewska1, R Rogoz.   

Abstract

The present study was designed to find out whether the prolonged administration of imipramine (IMI) or electroconvulsive shock (ECS) influences levels of endogenous enkephalins in the nucleus accumbens (NAS) and the ventral tegmentum (VTA) of the rat. Ressults indicate that treatment with IMI as well as with ECS has a profound effect on the levels of enkephalins in both structures. In the NAS both treatments lead to an increase in the levels of endogenous enkephalins and this effect is accompanied by an increase in mRNA coding for proenkephalin (measured by in situ hybridization) in this structure, indicating the enhancement of biosynthesis of endogenous enkephalinergic peptides following antidepressant treatment. The results are discussed in the light of the hypothesis concerning the influence of endogenous enkephalins on mesolimbic dopamine neurons, the activity of which plays a crucial role in the etiology of depression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8788070     DOI: 10.1007/bf01281156

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  20 in total

1.  Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.

Authors:  R Spanagel; A Herz; T S Shippenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

2.  Opioid peptides endorphins in pituitary and brain.

Authors:  A Goldstein
Journal:  Science       Date:  1976-09-17       Impact factor: 47.728

3.  Repeated administration of antidepressants enhances agonist affinity for mesolimbic D2-receptors.

Authors:  V Klimek; J Maj
Journal:  J Pharm Pharmacol       Date:  1989-08       Impact factor: 3.765

Review 4.  Anatomy of CNS opioid receptors.

Authors:  A Mansour; H Khachaturian; M E Lewis; H Akil; S J Watson
Journal:  Trends Neurosci       Date:  1988-07       Impact factor: 13.837

5.  Acute and repeated administration of sulpiride alters Met-and Leu-enkephalin content of rat brain.

Authors:  M L De Ceballos; P Jenner; C D Marsden
Journal:  Neurosci Lett       Date:  1986-08-04       Impact factor: 3.046

Review 6.  The psychotomimetic effects of opiates and the sigma receptor.

Authors:  J M Musacchio
Journal:  Neuropsychopharmacology       Date:  1990-06       Impact factor: 7.853

7.  Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine.

Authors:  P W Kalivas; R Abhold
Journal:  Brain Res       Date:  1987-06-30       Impact factor: 3.252

8.  A dynorphinergic pathway of Leu-enkephalin production in rat substantia nigra.

Authors:  N Zamir; M Palkovits; E Weber; E Mezey; M J Brownstein
Journal:  Nature       Date:  1984 Feb 16-22       Impact factor: 49.962

9.  Depletion of mesolimbic dopamine during behavioral despair: partial reversal by chronic imipramine.

Authors:  Z L Rossetti; M Lai; Y Hmaidan; G L Gessa
Journal:  Eur J Pharmacol       Date:  1993-10-05       Impact factor: 4.432

Review 10.  Brain dopamine and reward.

Authors:  R A Wise; P P Rompre
Journal:  Annu Rev Psychol       Date:  1989       Impact factor: 24.137

View more
  4 in total

1.  Influence of CGS 21680, a selective adenosine A(2A) agonist, on the phencyclidine-induced sensorimotor gating deficit and motor behaviour in rats.

Authors:  Jadwiga Wardas; Jolanta Konieczny; Małgorzata Pietraszek
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

2.  Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain.

Authors:  M Dziedzicka-Wasylewska; R Rogoz; V Klimek; J Maj
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Adaptive changes in the rat dopaminergic transmission following repeated lithium administration.

Authors:  M Dziedzicka-Wasylewska; M Maćkowiak; K Fijat; K Wedzony
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Effect of the combined use of tramadol and milnacipran on pain threshold in an animal model of fibromyalgia.

Authors:  Seong-Ho Kim; Junhwa Song; Hyunil Mun; Keon Uk Park
Journal:  Korean J Intern Med       Date:  2009-06-08       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.